- Exhibit & Support
- Hotel & Travel
To better understand type 2 diabetes management, you have to understand cardiovascular outcome trials (CVOTs). This interactive session will explore the unique properties, A1C-lowering effects, and CVOTs of dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, and sodium–glucose cotransporter 2 inhibitors. Using the data, participants will be able to better advise their patients on diabetes management and evaluate future CVOTs.
This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) recertification credit.
At the completion of this application-based activity, participants will be able to: